Ozempic
(semaglutide) NovoNordisk

Composition:
• Available in solution for subcutaneous injection with each single pre-filled pen contains 2 mg semaglutide in 1.5 ml solution or 4 mg semaglutide in 3.0 ml solution

Indication:
• For the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

　　• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications

　　• in addition to other medicinal products for the treatment of diabetes

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.
The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.